ReviewCirculation research2022
Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools.
Review in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A Systematic Review and Meta-Analysis of Breast Arterial Calcification and Its Association With Cardiovascular Disease and All-Cause Mortality.The American journal of cardiology · 2026Pooled it
- Digital Health Interventions for Heart Failure Management in Underserved Rural Areas of the United States: A Systematic Review of Randomized Trials.Journal of the American Heart Association · 2024Pooled it
- The digital heartbeat: a qualitative descriptive study on women's views on preventing cardiovascular disease in primary care.Family practice · 2026Article
- Sex-Specific Health and Economic Benefits in Older Women at Risk of Atrial Fibrillation: A Proof-of-Concept Evaluation of an AI-Enabled Strategy for Early Thromboembolic Risk Detection.Journal of clinical medicine · 2026Article
- Artificial intelligence in refractive surgery: progress, challenges, and future directions.Frontiers in cell and developmental biology · 2026Review
- Global burden and trend of ischemic heart disease and its attributable risk factors among women of childbearing age from 1990 to 2021.Frontiers in cardiovascular medicine · 2026Article
- Gender disparities in coronary artery disease: a review of factors influencing clinical outcomes.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025Review
- Sensitivity, specificity and prevalencesJournal of oral & facial pain and headache · 2025Article
- Advancing cardio-obstetric care through digital health technologies: A narrative review.ESC heart failure · 2025Review
- Artificial Intelligence in Postmenopausal Health: From Risk Prediction to Holistic Care.Journal of clinical medicine · 2025Review
- Integrating Large-Scale Data Analytics for Cardiovascular Disease Prediction: A Scoping Review.Healthcare informatics research · 2025Article
- Advances in artificial intelligence and precision nutrition approaches to improve maternal and child health in low resource settings.Nature communications · 2025Review
- Tailoring cardiovascular risk prediction to females.The Journal of endocrinology · 2025Review
- Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools.PLoS computational biology · 2025Article
- The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.Current cardiology reports · 2025Review
- Current status of modifiable risk factors for cardiovascular disease in Korean women.The Korean journal of internal medicine · 2025Review
- The impact of breast cancer radiation therapy exposure on the prevalence of breast arterial calcification.The British journal of radiology · 2024Article
- Artificial intelligence bias in the prediction and detection of cardiovascular disease.NPJ cardiovascular health · 2024Review
- Two-Stage Recruitment Design to Reduce Magnetic Resonance Imaging Screening Cost for a Theoretical Clinical Trial of White Matter Hyperintensity Progression.Journal of the American Heart Association · 2024Article
- Artificial Intelligence to Promote Racial and Ethnic Cardiovascular Health Equity.Current cardiovascular risk reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman's life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.